Persistent settling and waking difficulties, associated with disturbing behavior, restlessness, and intense crying, are encountered in up to 20% of infants under 1 year of age (1). The symptoms have been attributed to a variety of causes (2-6). In a preliminary study, we reported that the sleep of eight infants with chronic insomnia was normalized after these infants were fed a milk-free diet for a previously undiagnosed milk protein allergy (7). In the present study, we report on another group of patients with similar clinical symptoms and evolution.
Persistent settling and waking difficulties, associated with disturbing behavior, restlessness, and intense crying, are encountered in up to 20% of infants under 1 year of age (1) . The symptoms have been attributed to a variety of causes (2) (3) (4) (5) (6) . In a preliminary study, we reported that the sleep of eight infants with chronic insomnia was normalized after these infants were fed a milk-free diet for a previously undiagnosed milk protein allergy (7) . In the present study, we report on another group of patients with similar clinical symptoms and evolution.
PATIENTS AND INVESTIGATIONS
From July 1984 to July 1986, 71 infants were selected from an outpatient clinic and from the general pediatric ward. The infants were divided into three main groups according to the main complaints on presentation.
Group I: Insomnia
Of a total of 120 infants referred by their pediatricians for chronic waking and crying during sleep hours, 20 were selected because their sleep was severely disturbed, almost since the first days of life; an allergy to cow's milk protein was suspected because of family history of allergy and occasional mild episodes of diarrhea or skin rashes. An interview and a standard medical workup had failed to reveal any usual cause for the infant's poor sleep. An all-night polygraphic recording excluded further causes of arousals, such as obstructive sleep apneas (4) or
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esophageal reflux (5) . The recordings were normal for each infant, except that it confirmed the frequent awakenings and short total sleep time reported by the parents. These infants were thus further subjected to a series of allergy tests.
All cow's milk was then removed from the diet by feeding the infants exclusively for 4 weeks with a new routine hypoallergenic infant formula based on enzymatically hydrolyzed cow's milk whey proteins (Nestle). Follow-up interviews were conducted with the help of our dietician to evaluate the child's progress. During the treatment period the parents were asked to fill in a log describing the child's sleep schedule. After 4 weeks a second polygraphic recording was performed to confirm the reported increase in total sleep time and the decreased number of arousals. Milk was then reintroduced in the diet under close medical surveillance. The diagnosis of milk allergy was confirmed if sleeplessness and agitated behavior reappeared within 4 days. Cow's milk was then excluded again from the diet, and an improvement of the manifestations was to be obtained after the interruption of the milk challenge. Every infant in this group responded according to the protocol.
Group II: Milk Allergy
A group of 31 infants were referred with skin and digestive manifestations attributed to cow's milk allergy. After the introduction of cow's milk in their diet, these infants developed severe skin irritation, eczema (n=15), repeated airway infections, vomiting, or diarrhea (n = 28). The symptoms were attributed to cow's milk allergy by their referring pediatricians, and the same series of allergy tests was performed. The diagnosis was confirmed when the symptoms disappeared after the infants were fed with the milk-free diet (Alfare). Although none of the parents spontaneously complained about their infant's sleep, they were asked to fill in a sleep questionnaire and a sleep log for 4 weeks after the exclusion of milk from the diet. According to this information the group was further subdivided into two subgroups. Eighteen infants with a normal sleep behavior formed the "good sleepers" subgroup; 13 with frequent awakenings and short sleep time formed the "poor sleepers" subgroup.
Group III: Control Infants
A group of 20 normal infants was selected among children hospitalized for minor interventions or examinations. Although none had a previous history of sleep disturbance and allergy-related symptoms, the parents allowed blood to be taken to test for allergy and to fill in a sleep questionnaire. No further investigations or regimen was instituted for these infants.
Hypoallergenic Formula Characteristics
NAN H.A. is a hypoallergenic formula intended for routine feeding of infants, particularly those with a positive family history of allergy. Basic composition is quantitatively identical to that of starter infant formula and complies with the most recent pediatric recommendations. NAN H.A. is composed of the following: a demineralized whey concentrate hydrolyzed by trypsin under specific conditions (8); palm olein, high oleic safflower oil, and coconut oil; malto-dextrin (+ lactose present in trypsin hydrolyzed demineralized whey); and minerals, vitamins, lecithin, and taurine additions.
Composition
The composition of NAN H.A., per 100 kcal, is as follows: protein, 2.46 g; fat, 5.1 g; carbohydrates, 11 g; minerals, 0.45 g; plus some vitamins and trace elements.
Hypoallergenicity
During the development of this formula, solid-phase radioimmunoassay was performed in order to detect traces of residual beta-lactoglobulin. Furthermore, an oral sensitization test in animal models was used (9) . Hypoallergenicity is controlled on each batch by the following biochemical tests:
1. Electrophoresis [Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE)]. This technique allows detection of intact proteins or of large molecular weight peptides (>10 kilodaltons) 2. Double immunodiffusion (Ouchterlony test). Each lot is routinely controlled by double immunodiffusion according to Ouchterlony. At a test concentration of 50 mg/ml, there must be absence of any precipitation lines with anti-beta-lactoglobulin, anti-bovine serum albumin, and anti-alpha-lactalbumin sera. Ouchterlony double diffusion detects approximately 10 (xg/ml of beta-lactoglobulin or alpha-lactalbumin and 20 (ig/ml of serum albumin.
RESULTS
The main characteristics of the 71 infants are shown in Table 1 . The groups were comparable for age and sex of the infants. In group II, no family or personal characteristics differentiated the two subgroups of "good" and "poor sleepers," including the duration and apparent severity of their skin and digestive symptoms. The reported sleep duration significantly differentiated the three groups. The 20 infants in group I and the 18 "poor sleepers" in group II slept significantly less 
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The data are presented as absolute values, means, and standard deviations. *NS, not significant.
than the remaining 33 infants. No difference in total sleep time was seen between the infants in group I and the "poor sleepers" in group II, or between the "good sleepers" in group II and the infants in group III. All infants in group I and 18 "poor sleepers" in group II had two to nine arousals per night. The "good sleepers" in group II and the infants in group III had no arousal during the night or only awoke occasionally. The tests for milk protein allergy were positive for the 38 infants in groups I and II but were not positive for any of the infants of group III (Table 2) . Milk allergy was confirmed clinically by the favorable evolution during the exclusion diet for the infants in groups I and II and by the sleeplessness that followed the oral milk challenge in the infants in group I. Within 4 weeks of the milk-free diet, the sleep characteristics of all infants in group I and of the "poor sleepers" in group II normalized. Their sleep duration during the day, as well as during the night, could not be differentiated from that of the "good sleepers" in group II and of the control infants in group III (Table 3) . 
DISCUSSION
In the infants with chronic sleeplessness, an allergy to cow's milk was suspected from each infant's history and was confirmed by (a) the improvement in symptoms after milk was avoided, (b) the recurrence of symptoms after an oral challenge with milk, and (c) a new improvement of sleep after a second trial of milk elimination. When cow's milk is eliminated from the diet, each infant's sleep time became similar to that of normal control children of the same age. Still, three caveats must be mentioned about possible limitations of the dietary treatment of sleep. First, the exclusion of all cow's milk protein can be a tedious procedure, since many food preparations contain beta-lactoglobulin and other milk protein antigens. The accidental reintroduction of only small quantities of cow's milk protein into the infant's diet can cause the return of poor sleep. Second, soya milk may not be the best choice for replacement of cow's milk, since up to 5% of allergic infants can also suffer from soya protein intolerance (10) . In such a case the preference should be given to a hypoallergenic infant diet. Third, the diet should be maintained for at least 3 to 4 weeks before sleep normalizes. This implies that the families must be closely supported during the long treatment period. We don't know the prevalence of this cause of sleep disturbance in children, and we cannot yet explain the relation between milk allergy and sleeplessness. The poor sleep could be related to physical discomfort as well as to changes in metabolism of the central nervous system. We are unable to explain why 13 of the infants referred for atopy slept normally whereas 18 were poor sleepers. No significant difference was seen between the two groups of infants, either in their individual histories, clinically, or in laboratory tests. An immediate type of allergic reaction does not seem to account for the development of poor sleep, as indicated by the absence of elevated immunoglobin E levels in the blood of most infants. Further studies will be needed to clarify this question. We conclude that infants with clinically evident milk allergy may suffer from sleeplessness, although this sleep disturbance can be overlooked. Furthermore, when no evident cause for chronic insomnia can be found in an infant, the possibility of milk allergy should be given serious consideration.
